Artículos de revistas sobre el tema "Myocardial hypertrophy"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Myocardial hypertrophy".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Tang, Xin, Lihong Pan, Shuang Zhao, Feiyue Dai, Menglin Chao, Hong Jiang, Xuesong Li et al. "SNO-MLP (S-Nitrosylation of Muscle LIM Protein) Facilitates Myocardial Hypertrophy Through TLR3 (Toll-Like Receptor 3)–Mediated RIP3 (Receptor-Interacting Protein Kinase 3) and NLRP3 (NOD-Like Receptor Pyrin Domain Containing 3) Inflammasome Activation". Circulation 141, n.º 12 (24 de marzo de 2020): 984–1000. http://dx.doi.org/10.1161/circulationaha.119.042336.
Texto completoXue, Honghong, Hongtao Shi, Fan Zhang, Hao Li, Chao Li y Qinghua Han. "RIP3 Contributes to Cardiac Hypertrophy by Influencing MLKL-Mediated Calcium Influx". Oxidative Medicine and Cellular Longevity 2022 (14 de abril de 2022): 1–15. http://dx.doi.org/10.1155/2022/5490553.
Texto completoParker, Thomas G. y James N. Tsoporis. "Induction of S100β in Myocardium: An Intrinsic Inhibitor of Cardiac Hypertrophy". Canadian Journal of Applied Physiology 23, n.º 4 (1 de agosto de 1998): 377–89. http://dx.doi.org/10.1139/h98-022.
Texto completoTasnic, Mihail, Valeriu Revenco y Ilia Catereniuc. "Correlations of myocardial bridges with left ventricle myocardial hypertrophy and prepontin coronary atherosclerosis". Moldovan Medical Journal 64, n.º 5 (diciembre de 2021): 21–26. http://dx.doi.org/10.52418/moldovan-med-j.64-5.21.04.
Texto completoOuattara, Alexandre, Olivier Langeron, Rachid Souktani, Stéphane Mouren, Pierre Coriat y Bruno Riou. "Myocardial and Coronary Effects of Propofol in Rabbits with Compensated Cardiac Hypertrophy". Anesthesiology 95, n.º 3 (1 de septiembre de 2001): 699–707. http://dx.doi.org/10.1097/00000542-200109000-00024.
Texto completoLu, Dan, Jizheng Wang, Jing Li, Feifei Guan, Xu Zhang, Wei Dong, Ning Liu, Shan Gao y Lianfeng Zhang. "Meox1 accelerates myocardial hypertrophic decompensation through Gata4". Cardiovascular Research 114, n.º 2 (16 de noviembre de 2017): 300–311. http://dx.doi.org/10.1093/cvr/cvx222.
Texto completoChiu, Chiung-Zuan, Bao-Wei Wang, Tun-Hui Chung y Kou-Gi Shyu. "Angiotensin II and the ERK pathway mediate the induction of myocardin by hypoxia in cultured rat neonatal cardiomyocytes". Clinical Science 119, n.º 7 (22 de junio de 2010): 273–82. http://dx.doi.org/10.1042/cs20100084.
Texto completoLiu, Xiuhua, Tianbo Li, Sheng Sun, Feifei Xu y Yiguang Wang. "Role of myofibrillogenesis regulator-1 in myocardial hypertrophy". American Journal of Physiology-Heart and Circulatory Physiology 290, n.º 1 (enero de 2006): H279—H285. http://dx.doi.org/10.1152/ajpheart.00247.2005.
Texto completoLv, Shichao, Qiang Wang, Meifang Wu, Meng Li, Xiaojing Wang, Ling Xu y Junping Zhang. "QiShenYiQi Pill Improves Myocardial Hypertrophy Caused by Pressure Overload in Rats". Evidence-Based Complementary and Alternative Medicine 2021 (16 de junio de 2021): 1–10. http://dx.doi.org/10.1155/2021/5536723.
Texto completoZheng, Xi, Fuxiang Su, Ze Kang, Jingyuan Li, Chenyang Zhang, Yujia Zhang y Liying Hao. "Analysis of Therapeutic Targets of A Novel Peptide Athycaltide-1 in the Treatment of Isoproterenol-Induced Pathological Myocardial Hypertrophy". Cardiovascular Therapeutics 2022 (2 de mayo de 2022): 1–13. http://dx.doi.org/10.1155/2022/2715084.
Texto completoLiu, Yao-Lung, Chiu-Ching Huang, Chiz-Chung Chang, Che-Yi Chou, Shih-Yi Lin, I.-Kuan Wang, Dennis Jine-Yuan Hsieh, Gwo-Ping Jong, Chih-Yang Huang y Chao-Min Wang. "Hyperphosphate-Induced Myocardial Hypertrophy through the GATA-4/NFAT-3 Signaling Pathway Is Attenuated by ERK Inhibitor Treatment". Cardiorenal Medicine 5, n.º 2 (2015): 79–88. http://dx.doi.org/10.1159/000371454.
Texto completoNakamura, Teruya, Kunio Matsumoto, Shinya Mizuno, Yoshiki Sawa, Hikaru Matsuda y Toshikazu Nakamura. "Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts". American Journal of Physiology-Heart and Circulatory Physiology 288, n.º 5 (mayo de 2005): H2131—H2139. http://dx.doi.org/10.1152/ajpheart.01239.2003.
Texto completoKoga, Kiyokazu, Agnes Kenessey y Kaie Ojamaa. "Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy". American Journal of Physiology-Heart and Circulatory Physiology 304, n.º 2 (15 de enero de 2013): H282—H293. http://dx.doi.org/10.1152/ajpheart.00595.2012.
Texto completoLeontyeva, I. V., N. V. Shcherbakova, E. P. Kalachanova, S. A. Thermosesov y V. S. Sukhorukov. "Hypertrophic cardiomyopathy caused by mutations in the <I>PRKAG2</I> gene". Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 67, n.º 4 (21 de septiembre de 2022): 99–107. http://dx.doi.org/10.21508/1027-4065-2022-67-4-99-107.
Texto completoJi, Xiao-Bing, Xiu-Rong Li, Hao-Ding, Qi Sun, Yang Zhou, Ping Wen, Chun-Sun Dai y Jun-Wei Yang. "Inhibition of Uncoupling Protein 2 Attenuates Cardiac Hypertrophy Induced by Transverse Aortic Constriction in Mice". Cellular Physiology and Biochemistry 36, n.º 5 (2015): 1688–98. http://dx.doi.org/10.1159/000430142.
Texto completoChernykh, N. Yu, A. A. Tarasova, O. S. Groznova y I. M. Shigabeev. "Left ventricular myocardial strain and electrocardiographic changes in children with hypertrophic cardiomyopathy". Meditsinskiy sovet = Medical Council, n.º 11 (12 de agosto de 2021): 124–32. http://dx.doi.org/10.21518/2079-701x-2021-11-124-132.
Texto completoAluja, David, Sara Delgado-Tomás, Marisol Ruiz-Meana, José A. Barrabés y Javier Inserte. "Calpains as Potential Therapeutic Targets for Myocardial Hypertrophy". International Journal of Molecular Sciences 23, n.º 8 (7 de abril de 2022): 4103. http://dx.doi.org/10.3390/ijms23084103.
Texto completoWang, Hui, Yuqin Zhang, Shuwen Guo, Jiani Wu, Wang’ou Lin, Binyue Zhang, Pengfei Feng et al. "Effects of Yiqi Huoxue Decoction on Post-Myocardial Infarction Cardiac Nerve Remodeling and Cardiomyocyte Hypertrophy in Rats". Evidence-Based Complementary and Alternative Medicine 2021 (21 de agosto de 2021): 1–16. http://dx.doi.org/10.1155/2021/5168574.
Texto completoChen, Chao-Yi, Jyh-Gang Leu, Kuan-Yu Lin, Chin-Yu Shih y Yao-Jen Liang. "Serotonin receptor subtype-2B signaling is associated with interleukin-18-induced cardiomyoblast hypertrophy in vitro". Asian Biomedicine 16, n.º 2 (1 de abril de 2022): 79–87. http://dx.doi.org/10.2478/abm-2022-0010.
Texto completoXia, Huiting, Aqeela Zahra, Meng Jia, Qun Wang, Yunfu Wang, Susan L. Campbell y Jianping Wu. "Na+/H+ Exchanger 1, a Potential Therapeutic Drug Target for Cardiac Hypertrophy and Heart Failure". Pharmaceuticals 15, n.º 7 (15 de julio de 2022): 875. http://dx.doi.org/10.3390/ph15070875.
Texto completoBishop, Sanford P. "The Myocardial Cell: Normal Growth, Cardiac Hypertrophy and Response to Injury". Toxicologic Pathology 18, n.º 4a (enero de 1990): 438–53. http://dx.doi.org/10.1177/0192623390004part_102.
Texto completoNakata, Yohei, Muneo Yoshibayashi, Toshiya Yonemura, Shinji Uemoto, Yukihiro Inomata, Koichi Tanaka y Kenshi Furusho. "TACROLIMUS AND MYOCARDIAL HYPERTROPHY". Transplantation 69, n.º 9 (mayo de 2000): 1960–62. http://dx.doi.org/10.1097/00007890-200005150-00039.
Texto completoSuzuki, Jun-ichi, Hiroki Sato, Makoto Kaneko, Asuka Yoshida, Norio Aoyama, Shouta Akimoto, Kouji Wakayama et al. "Periodontitis and myocardial hypertrophy". Hypertension Research 40, n.º 4 (10 de noviembre de 2016): 324–28. http://dx.doi.org/10.1038/hr.2016.146.
Texto completoNakagami, Hironori y James K. Liao. "Statins and myocardial hypertrophy". Coronary Artery Disease 15, n.º 5 (agosto de 2004): 247–50. http://dx.doi.org/10.1097/01.mca.0000130229.18685.b9.
Texto completoSugden, Peter H. "Signaling in Myocardial Hypertrophy". Circulation Research 84, n.º 6 (2 de abril de 1999): 633–46. http://dx.doi.org/10.1161/01.res.84.6.633.
Texto completoHirsch, Alan T., John A. Opsahl, Mary M. Lunzer y Stephen A. Katz. "Active renin and angiotensinogen in cardiac interstitial fluid after myocardial infarction". American Journal of Physiology-Heart and Circulatory Physiology 276, n.º 6 (1 de junio de 1999): H1818—H1826. http://dx.doi.org/10.1152/ajpheart.1999.276.6.h1818.
Texto completoChen, Yintao, Ye Chang, Naijin Zhang, Xiaofan Guo, Guozhe Sun y Yingxian Sun. "Atorvastatin Attenuates Myocardial Hypertrophy in Spontaneously Hypertensive Rats via the C/EBPβ/PGC-1α/UCP3 Pathway". Cellular Physiology and Biochemistry 46, n.º 3 (2018): 1009–18. http://dx.doi.org/10.1159/000488832.
Texto completoHan, Jibo, Shanshan Dai, Lingfeng Zhong, Xiaowen Shi, Xiaoxi Fan, Xin Zhong, Wante Lin et al. "GSDMD (Gasdermin D) Mediates Pathological Cardiac Hypertrophy and Generates a Feed-Forward Amplification Cascade via Mitochondria-STING (Stimulator of Interferon Genes) Axis". Hypertension 79, n.º 11 (noviembre de 2022): 2505–18. http://dx.doi.org/10.1161/hypertensionaha.122.20004.
Texto completoShen, Linyuan, Mailin Gan, Zhengdong Tan, Dongmei Jiang, Yanzhi Jiang, Mingzhou Li, Jinyong Wang, Xuewei Li, Shunhua Zhang y Li Zhu. "A Novel Class of tRNA-Derived Small Non-Coding RNAs Respond to Myocardial Hypertrophy and Contribute to Intergenerational Inheritance". Biomolecules 8, n.º 3 (16 de julio de 2018): 54. http://dx.doi.org/10.3390/biom8030054.
Texto completoTsuda, Takeshi. "Clinical Assessment of Ventricular Wall Stress in Understanding Compensatory Hypertrophic Response and Maladaptive Ventricular Remodeling". Journal of Cardiovascular Development and Disease 8, n.º 10 (29 de septiembre de 2021): 122. http://dx.doi.org/10.3390/jcdd8100122.
Texto completoDung, Van Hung, Pham Thanh Binh, Nguyen Tien Hoa y Bui Minh Trang. "Case report: Bilateral hypertrophic obstructive cardiomyophathy associated with myocardial bridge". Tạp chí Phẫu thuật Tim mạch và Lồng ngực Việt Nam 39 (31 de octubre de 2022): 122–25. http://dx.doi.org/10.47972/vjcts.v39i.810.
Texto completoTennant, Bryn. "Small Animal Review". Companion Animal 25, n.º 5 (2 de junio de 2020): 110. http://dx.doi.org/10.12968/coan.2020.0043.
Texto completoStrøm, Claes C., Mogens Kruhøffer, Steen Knudsen, Frank Stensgaard-Hansen, Thomas E. N. Jonassen, Torben F. Ørntoft, Stig Haunsø y Søren P. Sheikh. "Identification of a Core Set of Genes That Signifies Pathways Underlying Cardiac Hypertrophy". Comparative and Functional Genomics 5, n.º 6-7 (2004): 459–70. http://dx.doi.org/10.1002/cfg.428.
Texto completoLorén, Christina, Christen Dahl, Lan Do, Vibeke Almaas, Odd Geiran, Stellan Mörner y Urban Hellman. "Low Molecular Mass Myocardial Hyaluronan in Human Hypertrophic Cardiomyopathy". Cells 8, n.º 2 (29 de enero de 2019): 97. http://dx.doi.org/10.3390/cells8020097.
Texto completoBasargina, E. N., V. S. Ermolenko y I. V. Sil’nova. "Myocardial hypertrophy in infants in pediatric practice". Kazan medical journal 96, n.º 4 (15 de agosto de 2015): 647–53. http://dx.doi.org/10.17750/kmj2015-647.
Texto completoZhu, Huiping, Liutong Pan, Yuanting Dai, Dan Zheng y Shasha Cai. "Role of TLR4/MyD88 Signaling Pathway in the Occurrence and Development of Uremia-Induced Myocardial Hypertrophy and Possible Mechanism". Evidence-Based Complementary and Alternative Medicine 2021 (13 de octubre de 2021): 1–9. http://dx.doi.org/10.1155/2021/7883643.
Texto completoCalamaras, Timothy D., Robert A. Baumgartner, Mark J. Aronovitz, Angela L. McLaughlin, Kelly Tam, Daniel A. Richards, Craig W. Cooper et al. "Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload". American Journal of Physiology-Heart and Circulatory Physiology 316, n.º 1 (1 de enero de 2019): H145—H159. http://dx.doi.org/10.1152/ajpheart.00029.2018.
Texto completoZhao, Mingyue, Lihui Lu, Song Lei, Hua Chai, Siyuan Wu, Xiaoju Tang, Qinxue Bao, Li Chen, Wenchao Wu y Xiaojing Liu. "Inhibition of Receptor Interacting Protein Kinases Attenuates Cardiomyocyte Hypertrophy Induced by Palmitic Acid". Oxidative Medicine and Cellular Longevity 2016 (2016): 1–13. http://dx.doi.org/10.1155/2016/1451676.
Texto completoMing, Sitong, Mo Kan, Liu Liu, Zhuang Zhang, Xiaoran Liu, Yaxin Liu, Zhen Li et al. "Protective Effect of Shengmaiyin in Myocardial Hypertrophy-Induced Rats: A Genomic Analysis by 16S rDNA". Evidence-Based Complementary and Alternative Medicine 2022 (7 de septiembre de 2022): 1–17. http://dx.doi.org/10.1155/2022/3188292.
Texto completoSharma, Jayendra, William Hellenbrand, Charles Kleinman y Ralph Mosca. "Symptomatic myocardial bridges in children: a case report with review of literature". Cardiology in the Young 21, n.º 5 (23 de junio de 2011): 490–94. http://dx.doi.org/10.1017/s1047951111000849.
Texto completoJain, Mohit, Ronglih Liao, Bruno K. Podesser, Soeun Ngoy, Carl S. Apstein y Franz R. Eberli. "Influence of gender on the response to hemodynamic overload after myocardial infarction". American Journal of Physiology-Heart and Circulatory Physiology 283, n.º 6 (1 de diciembre de 2002): H2544—H2550. http://dx.doi.org/10.1152/ajpheart.00338.2002.
Texto completoKatz, Stephen A., John A. Opsahl, Shane E. Wernsing, Lynn M. Forbis, Juline Smith y Lois J. Heller. "Myocardial renin is neither necessary nor sufficient to initiate or maintain ventricular hypertrophy". American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 278, n.º 3 (1 de marzo de 2000): R578—R586. http://dx.doi.org/10.1152/ajpregu.2000.278.3.r578.
Texto completoSarkar, Sagartirtha, Douglas W. Leaman, Sudhiranjan Gupta, Parames Sil, David Young, Annitta Morehead, Debabrata Mukherjee et al. "Cardiac Overexpression of Myotrophin Triggers Myocardial Hypertrophy and Heart Failure in Transgenic Mice". Journal of Biological Chemistry 279, n.º 19 (16 de febrero de 2004): 20422–34. http://dx.doi.org/10.1074/jbc.m308488200.
Texto completoLiu, Lei, Chao Wang, Dianjun Sun, Shuangquan Jiang, Hong Li, Weihua Zhang, Yajun Zhao et al. "Calhex231 Ameliorates Cardiac Hypertrophy by Inhibiting Cellular Autophagy in Vivo and in Vitro". Cellular Physiology and Biochemistry 36, n.º 4 (2015): 1597–612. http://dx.doi.org/10.1159/000430322.
Texto completoIswara, Raja Al Fath Widya, Arif Rahman Sadad, Intarniati Nur Rohmah y Sigid Kirana Lintang Bhima. "Kematian Mendadak Akibat Kardiomiopati Hipertrofi Pada Dewasa Muda". Medica Hospitalia : Journal of Clinical Medicine 7, n.º 2 (19 de noviembre de 2020): 470–75. http://dx.doi.org/10.36408/mhjcm.v7i2.522.
Texto completoSui, Xin, Na Li, Xiaozheng Shi, Xiaohua Li, Dong Han, Zhidong Qiu, Yue Deng y Guangwei Sun. "Pinocembrin Protects Cardiomyocytes Against Isoproterenol-Induced Hypertrophy". Natural Product Communications 16, n.º 8 (agosto de 2021): 1934578X2110332. http://dx.doi.org/10.1177/1934578x211033216.
Texto completoGarcía-Díaz, Lutgardo, Félix Coserria y Guillermo Antiñolo. "Hypertrophic Cardiomyopathy due to Mitochondrial Disease: Prenatal Diagnosis, Management, and Outcome". Case Reports in Obstetrics and Gynecology 2013 (2013): 1–4. http://dx.doi.org/10.1155/2013/472356.
Texto completoBupha-Intr, Tepmanas, Jeffrey W. Holmes y Paul M. L. Janssen. "Induction of hypertrophy in vitro by mechanical loading in adult rabbit myocardium". American Journal of Physiology-Heart and Circulatory Physiology 293, n.º 6 (diciembre de 2007): H3759—H3767. http://dx.doi.org/10.1152/ajpheart.01267.2006.
Texto completoMorgan, Howard E. "Signal transduction in myocardial hypertrophy." Keio Journal of Medicine 39, n.º 1 (1990): 1–5. http://dx.doi.org/10.2302/kjm.39.1.
Texto completoZhang, Jianyi. "Myocardial Energetics In Cardiac Hypertrophy". Clinical and Experimental Pharmacology and Physiology 29, n.º 4 (abril de 2002): 351–59. http://dx.doi.org/10.1046/j.1440-1681.2002.03657.x.
Texto completo